Efficacy Prediction of Neoadjuvant Combination
Therapy for Esophageal Squamous Cell Carcinoma
Enter your parameters
PD-L1 expression(%)
Lymphocyte count(10^9/L)
Cancer Antigen 125(U/ml)
Platelet count(10^9/L)
Monocyte / Lymphocyte
Albumin(g/L)
Red blood cell(10^12/L)
Fasting Blood Glucose(mmo/L)
Neutrophil / Lymphocyte
Albumin / Lymphocyte
SUBMIT
